[VRTX] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
08-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -304.50%
YoY- -436.30%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 398,080 138,509 118,451 328,368 438,737 73,662 22,429 61.43%
PBT -30,617 -198,405 -231,654 -442,940 87,908 -176,096 -165,271 -24.47%
Tax 5,485 299 803 -130,313 32 8,099 -1,815 -
NP -41,631 -198,606 -232,457 -308,016 91,590 -176,096 -165,271 -20.51%
Tax Rate - - - - -0.04% - - -
Total Cost 439,711 337,115 350,908 636,384 347,147 249,758 187,700 15.22%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -10.46 -143.39 -196.25 -93.80 20.88 -239.06 -736.86 -50.76%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -0.17 -0.83 -1.00 -1.43 0.44 -0.87 -0.83 -23.20%
EPS Diluted -0.17 -0.83 -1.00 -1.43 0.43 -0.87 -0.83 -23.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.